Axxcess Wealth Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $158K | Buy |
13,669
+536
| +4% | +$6.21K | ﹤0.01% | 855 |
|
|
2025
Q1 | $115K | Buy |
13,133
+482
| +4% | +$4.21K | ﹤0.01% | 830 |
|
|
2024
Q4 | $182K | Sell |
12,651
-2,667
| -17% | -$38.3K | ﹤0.01% | 825 |
|
|
2024
Q3 | $346K | Buy |
15,318
+4,258
| +38% | +$96.1K | 0.01% | 645 |
|
|
2024
Q2 | $215K | Buy |
11,060
+4,743
| +75% | +$92.3K | 0.01% | 768 |
|
|
2024
Q1 | $237K | Buy |
+6,317
| New | +$237K | 0.01% | 750 |
|
|
2022
Q2 | – | Sell |
-3,472
| Closed | -$264K | – | 664 |
|
|
2022
Q1 | $264K | Sell |
3,472
-898
| -21% | -$68.3K | 0.02% | 504 |
|
|
2021
Q4 | $651K | Buy |
+4,370
| New | +$651K | 0.05% | 302 |
|